CURE’s prostate cancer page is an extensive resource of cancer information featuring the latest prostate cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on prostate cancer.
May 14th 2025
The addition of Erleada to ADT may provide less benefit in patients with metastatic castration-sensitive prostate cancer and fewer bone metastases.
Nubeqa Outperforms Xtandi, Erleada in Non-metastatic Castration-resistant Prostate Cancer
February 16th 2023Patients treated with Nubeqa were less likely to develop disease metastasis or discontinue treatment 6 to 18 months after ARI course start compared to Xtandi or Erleada, according to data presented at ASCO GU.
Phase 3 Trial in Prostate Cancer Subset Discontinued Due to Lack of Survival Benefit
January 26th 2023A data monitoring committee recommended to stop the phase 3 trial in metastatic hormone-sensitive prostate cancer due to a lack of progression-free survival and overall survival with combination therapy.
Tina Turner’s Son Dies of Cancer, NFL Team Honors Group’s $5.6 Million Fundraising Effort and More
December 16th 2022From Tina Turner’s son, Ronnie, dying of cancer to the Miami Dolphins honoring a group of people who raised over $5 million for oncology care and research, here is what’s happening in the cancer space this week.